🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Comparison of olaparib vs. physician's choice of single agent standard of c...
Status
Completed
Location
Research Site
Start Date
2015-02-06
Trial ID
NCT02282020
Treatments Being Tested
The primary scientific question of interest of this study is whether the co...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-09-15
Trial ID
NCT05809895
Treatments Being Tested
This was an open-label, nonrandomized, Phase 1/2 study designed to determin...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2017-05-02
Trial ID
NCT03085914
This study is a randomized controlled, open-label, multicenter phase III cl...
Status
Recruiting
Location
Erwei Song
Start Date
2023-12-01
Trial ID
NCT06079983
This study will evaluate the surgical safety and feasibility of atezolizuma...
Status
Terminated
Location
City of Hope Cancer Center
Start Date
2021-04-23
Trial ID
NCT04832854
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of an investigational...
Status
Recruiting
Location
The University of Arizona Cancer Center-North Campus
Start Date
2026-05-22
Trial ID
NCT07621718
This is an open-label, multicenter, randomized, phase 3 trial to evaluate t...
Status
Unknown
Location
Affiliated Cancer Hospital and Institute of Guangzhou Medical University
Start Date
2022-02-15
Trial ID
NCT05244642
Treatments Being Tested
This study is designed to determine the efficacy and safety of durvalumab a...
Status
Active Not Recruiting
Location
Research Site
Start Date
2018-12-27
Trial ID
NCT03819465
The aim of evaluating the efficacy and safety of cadonilimab combined with ...
Status
Recruiting
Location
Department of Medical Oncology, Central Hospital of Yichang City, the First Clinical Medical College of Three Gorges University
Start Date
2024-03-01
Trial ID
NCT06467500
Treatments Being Tested
The purpose of this study is to compare progression free survival for SU011...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2006-01
Trial ID
NCT00246571
Treatments Being Tested